NCT01614990View on ClinicalTrials.gov

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

PHASE2CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2020

Study Completion Date

December 31, 2021

Conditions

Cancer Cachexia

Interventions

DRUG

Macimorelin

Subjects will receive macimorelin (1 mg/kg) and matching placebo (Powerade®) daily for 7 days.

DRUG

Placebo

placebo (Powerade®) daily for 7 days.

Trial Locations (1)

98108

Veterans Affairs Puget Sound Health Care System, Seattle

Sponsors

Collaborators (1)

AEterna Zentaris

All Listed Sponsors

collaborator

VA Office of Research and Development

FED

collaborator

Baylor College of Medicine

OTHER

collaborator

AEterna Zentaris

INDUSTRY

lead

Garcia, Jose M., MD, PhD

INDIV